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Prescription medication borrowing and sharing: risk factors and management
Abstract
Background Prescription medication borrowing and sharing is a behaviour that has been identified in
patients of all ages. This behaviour is recognised by medical researchers and government health
authorities as a potential risk factor in adverse drug events across the community. Objective This article
discusses prescription medication borrowing and sharing and identifies populations more likely to
participate in this behaviour. It also focuses on the classes of drugs identified in the research literature as
those being more likely to be borrowed or shared. Discussion Prescription medication borrowing and
sharing behaviours have been associated with several risk factors such as polypharmacy and multiple
chronic comorbidities. General practitioners and health professionals are therefore encouraged to
counsel patients, at the time of issuing prescriptions and following discharge from hospital, on the risks
of borrowing and sharing prescription medications and the safe disposal of ‘left over’ prescription
medications.
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Prescription medication
borrowing and sharing
Risk factors and management
Background
Prescription medication borrowing and sharing is a behaviour
that has been identified in patients of all ages. This behaviour
is recognised by medical researchers and government health
authorities as a potential risk factor in adverse drug events across
the community.

Objective
This article discusses prescription medication borrowing and sharing
and identifies populations more likely to participate in this behaviour.
It also focuses on the classes of drugs identified in the research
literature as those being more likely to be borrowed or shared.

Discussion
Prescription medication borrowing and sharing behaviours have
been associated with several risk factors such as polypharmacy
and multiple chronic comorbidities. General practitioners and health
professionals are therefore encouraged to counsel patients, at the
time of issuing prescriptions and following discharge from hospital,
on the risks of borrowing and sharing prescription medications and
the safe disposal of ‘left over’ prescription medications.
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Prescription medication borrowing and sharing (PMBS) is
a patient behaviour that negatively affects patient quality use
of medicine. 1 This behaviour is recognised by medical
practitioners, researchers and government health authorities
as a risk factor in medication errors which results in adverse
drug events (ADEs).2–4 Despite this, many studies examining
the risk factors for ADEs do not directly examine PMBS
behaviour. Any evidence reported usually categorises PMBS
under the umbrella terms ‘medication error’2,4 or ‘medication
misadventure’;5 or may be referred to obliquely as ‘use of
inappropriate medicine’.4 The danger with this is that there is
a risk of underestimating the impact of this behaviour on the
incidence of ADEs.
An adverse drug event is defined as ‘harm that results from the
intrinsic nature of a medication (an adverse drug reaction) as well
as harm that results from medication errors associated with the
manufacture, distribution or use of medicines’.2 ‘Borrowing’ a
prescription medication has been defined by Goldsworthy et al3 as the
patient taking a medication prescribed for someone else. ‘Sharing’ (or
‘loaning’) means that the patient gives their prescribed medication to
someone else.3
The impact of ADEs in Australia is significant in terms of cost to
both the government and community.2 In the Second National Report
on Patient Safety4 it is noted that, of the 100 million general practice
encounters every year in Australia, around 400 000 are associated
with an ADE.4 Furthermore, it is estimated that around half of drug
related hospitalisations in Australia are most likely preventable,5 and
pre-admission ADEs are implicated in around half of hospitalisations.6
It is acknowledged that, due to difficulties in collecting data
from community based incidents, the actual number of ADEs due
to medication error can only be estimated.2,4 Systems can be put
in place to measure and monitor inappropriate dose or medication
administration while a patient is under the care of health professionals
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in a hospital setting; however, this is more difficult when a patient
is at home. One major issue reported in research literature is
changes to patient medication regimens during hospitalisation and
how these changes are communicated to the patient’s primary care
physician through the discharge summary.7 There is a possibility that
complications may arise: for example, if a medication is discontinued
the patient may not be counselled about correctly disposing of
leftover medications at home, this may lead to possible hoarding of
prescription medications, which in turn can facilitate PMBS behaviour
and possible ADEs due to the availability of ‘spare’ medication.
Literature and reviews on ADEs in hospital and ambulatory care
have pinpointed several risk factors for ADEs. These include the
increased age of the patient, multiple medications (polypharmacy),
and an increased number of chronic, comorbid conditions.2,5,8–10 As
there is no complete, reliable, single source of data, 2 due in part
to there being no centralised reporting system for ‘minor’ ADEs (ie.
those that do not cause fatalities nor lasting morbidity),8,10 there may
be more risk factors that have not yet been identified.

Different populations
Research has found PMBS behaviour is prevalent across all
ages.3,11,12 There are similar issues with PMBS in all ages; however,
there are also age specific and cultural issues which have been
identified.
Patients who self medicate appropriately with over-the-counter
(OTC) medications are the main focus of research studies.12–14 In
general, this behaviour is considered benign, although a subgroup of
‘unsafe self medicators’ has been described in a survey of Spanish
participants aged 16 years and over.12 This description refers to the
taking of prescription or restricted medicines without professional
medical supervision12 and it is assumed that this behaviour also
includes PMBS. In this study, the characteristics of these ‘unsafe self
medicators’ included female gender, living alone, being retired and
being older.12
Very few studies since 2000 focus directly on PMBS behaviour.
Two American studies looked at populations aged 12–44 years. In
both studies it was found that around one-quarter of respondents
reported sharing or borrowing prescription medications;3,11 usually
asthma,11 allergy, pain relief3 and antibiotic medications3 (Table 1).
The incidence of this behaviour was higher in those aged 18–35
years,3 peaking in the early 20s.11
In a review of medication use among older Australians it was
found that 13–20% reported sharing prescription medications.15 In
common with the younger populations previously discussed,3,11 older
Australians were willing to share medication(s) previously prescribed
for them if they had run out of that medication.15 Borrowing ‘new’
medication was not as acceptable, with only 2% reporting to have
borrowed a prescription drug never prescribed for them.15
A recent small, qualitative Australian study looking at medication
management habits of non-English speaking background (Chinese
and Arabic) residents in southwestern Sydney found that a significant

Table 1. Conditions facilitating PMBS, as identified in
research literature
More likely to share with a family member
Share with someone else, if they had the same prescription
Borrower had run out of prescription medicine in the short term
Wanting to ‘help a friend’
Had ‘leftover’ medicine – kept deliberately for ‘next time’
Non-English speaking background
More people in the house
Single (not in a relationship)
Wanting same medication as other family member
proportion of these people practised PMBS behaviour. Researchers
identified several factors that facilitated this behaviour (Table 1),1
most of which were similar to American studies.3,11 In particular,
people in this population were more likely to share prescription
medicine with a family member, kept ‘leftover’ medicine for ‘next
time’ and asked their GP for the same medication that a family
member had been prescribed.1
Australians aged over 60 years have also been found to share,
stockpile and hoard their prescription medications.5,15,6 The reported
rates of elderly people stockpiling and hoarding prescription
medicine varied from 0.9% 5 to over 42%. 16 It should be noted
however, that these results are based on small studies, usually
related to the home medicine review (HMR) process. Perhaps as
a result of people hoarding medicines, a significant number of
elderly respondents were found to have expired medicines in their
home.5 Higher numbers of medications in an elderly person’s home
(prescription and OTC medications) have been found to have a
significant correlation with severity of illness and worsened health
status, 17 including increased risk of ADEs. 17 No definitive data
on the link between hoarding medicines and PMBS has been
collected or reported.4

Medications most likely to be borrowed or shared
Several classes of drugs (Table 2) have been identified as being
borrowed or shared for the treatment of both acute and chronic health
conditions. In particular, pain medications are commonly borrowed
or shared, including nonsteroidal anti-inflammatory agents (NSAIDs)
and the stronger opioids.12,18,19 Antibiotics also appear to be major
contributors to borrowing and sharing behaviours.
The use of NSAIDS have been implicated in ‘medication
misadventures’ due to inappropriate use or use of expired
medications,5 behaviours which encompass PMBS. The unmonitored
long term use of NSAIDS18 has the potential for ADEs, particularly
drug-drug interactions with prescribed medications. Examples of
these interactions include an exacerbation of bleeding when used in
combination with anticoagulants (eg. heparin and warfarin),2,5 and
cardiac complications when used in combination with cardiovascular
medications (eg. antihypertensives and digoxin).2,5
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Table 2. Classes of drugs implicated in PMBS, as identified in
research literature
Opioid analgesics
Other pain medications
NSAIDs
Allergy medications
Antibiotics
Anticoagulants
Cardiovascular medications

Table 3. Possible impacts of prescription medication borrowing
and sharing
Complications of incorrect use
Drug-drug interactions
Development of antibiotic resistance (due to people not following
the full course of antibiotics)
Addiction/misuse of addictive medications (leading to personal
and societal consequences of such abuse)
Reduced care seeking (delays in seeking professional medical
help can lead to misdiagnosis or diagnosis of a disease at a later
stage, leading to poorer outcomes)
Increased patient perception of ineffective treatment (due to patient
not taking an appropriate dose or medication for his/her condition)
Poisoning of patient due to inappropriate dose
Damage to fetus during early pregnancy
Much of the focus of borrowing and sharing associated with
opioid analgesics is on the illegal diversion of these medications,3
with sourcing such medications from family members (through
stealing or coercion) being recognised as a significant factor in this
behaviour.20
The final class of drugs, and of concern worldwide, is the use of
unprescribed antibiotics, which has been identified as a risk factor in the
development of antibiotic resistant bacteria.21–23 In a European study
into antibiotic use by adults, it was found that 46% of respondents (n=15
548) used leftover antibiotics (antibiotics not used at the end of a course
of antibiotics)22 when they believed that the infection had returned. This
behaviour has also been observed in Australia,1 with patients admitting
to keeping leftover antibiotics ‘for next time’.1

Impacts of borrowing and sharing prescription
medications
One of the few studies into PMBS behaviour by Goldsworthy,
Schwartz and Mayhorn3 led to the framing of a theoretical model.3
This model describes the mechanisms and outcomes of this
behaviour, positing possible individual and societal impacts. A study
by Petersen et al11 adds to the impacts component of the model
(Table 3).
The risk of drug-drug interactions, poisoning and the development
of antibiotic resistant strains of pathogens are readily recognised
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impacts of PMBS behaviour. Other impacts related to patient
perception of the effectiveness of medication treatments or physician
care are less often discussed and are more difficult to manage.

Discussion
Several risk factors and characteristics have been identified which
may be associated with PMBS behaviours, providing a theoretical
picture of a patient who is more likely to borrow or share prescription
medications (Table 1).
Prescription medication borrowing and sharing is acknowledged
as being commonplace among patients; however, possibly due to the
difficulties in collecting data on ADEs occurring in the community, little
evidence has been collected on the prevalence and the incidence of this
behaviour associated with ADEs. Further research into PMBS behaviour
in elderly patients and those with chronic comorbid health conditions in
particular, needs to be conducted as this group are at most risk of poor
health outcomes or ADEs as a result of this behaviour.
General practitioners and other health professionals should be
proactive in helping patients manage their prescription medications
safely. In every day practice strategies such as education, and
encouragement and reinforcement to discourage the practice of
borrowing and sharing prescribed medications should be considered.
Patients recently discharged from hospital should have their
current medication regimens reconciled. That is, a check of the
medications listed on the patient’s discharge summary should be
made and the patient consulted to determine which medications
are still being taken, and that the patient is managing their new
medication regimen safely having appropriately discarded
medications no longer required.
Patients should also be counselled at the time of prescribing,
especially the identified ‘at risk’ medications (eg. antibiotics, NSAIDs,
strong painkillers), that these medications are for their use only and
that they should not be shared with family or friends. Likewise, any
changes to a patient’s medication regimens should include discussion
about how patients should safely dispose of unwanted leftover
prescription medications.
Conflict of interest: none declared.

Acknowledgment

This paper was written as a Summer Scholarship Project for the Faculty of
Health and Behavioral Sciences, University of Wollongong, NSW, 2008–2009.

References
1.
2.
3.
4.

Bolton P, Hammoud S, Leung J. Issues in quality use of medicines in two non–
English speaking background communities. Australian Journal of Primary Health
2002;8:75–80.
Runciman WB, Roughead EE, Semple SJ, Adams RJ. Adverse drug events and
medication errors in Australia. Int J Qual Health Care 2003;15:i49–59.
Goldsworthy RC, Schwartz NC, Mayhorn CB. Beyond abuse and exposure:
Framing the impact of prescription-medication sharing. Am J Public Health
2008;98:1115–21.
Australian Council for Safety and Quality in Health Care. Second national
report on patient safety – Improving medication safety. Canberra: Australian
Commission on Safety and Quality in Health Care, 2002.

Prescription medication borrowing and sharing – risk factors and management professional practice

5.
6.

7.

8.
9.
10.

11.

12.
13.
14.

15.
16.

17.

18.

19.
20.
21.

22.

23.

Roughead EE, Barratt JD, Gilbert AL. Medication-related problems commonly
occurring in an Australian community setting. Pharmacoepidemiol Drug Saf
2004;13:83–7.
Forster AJ, Asmis TR, Clark HD, et al. Ottawa Hospital Patient Safety Study:
Incidence and timing of adverse events in patients admitted to a Canadian
teaching hospital. Can Med Assoc J 2004;170:1235–9.
JohnstoneK, Bagnall F, Kam Yin Chan D. Discharge summaries in aged care:
Improving communication between an aged care unit and general practitioners.
Australas J Ageing 2003;22:213–4.
Miller GC, Britt HC, Valenti L. Adverse drug events in general practice patients
in Australia. Med J Aust 2006;184:321–4.
Ho L, Lim AK, Tanner F. Renal failure and acute interstitial nephritis associated
with NSAIDs. Journal of Pharmacy Practice and Research 2005;35:219–21.
Nebeker JR, Barach P, Samore MH. Clarifying adverse drug events: A clinician’s guide to terminology, documentation and reporting. Ann Intern Med
2004;140:795–801.
Petersen EE, Rasmussen SA, Daniel KL, Yazdy MM, Honein MA. Prescription
medication borrowing and sharing among women of reproductive age. J
Womens Health 2008;17:1073–80.
Figueiras A, Caamano F, Gestal-Otero JJ. Sociodemographic factors related to
self-medication in Spain. Eur J Epidemiol 2000;16:19–26.
Awad AI, Eltayed IB, Capps PA. Self-medication practices in Khartoum State,
Sudan. Eur J Clin Pharmacol 2006;62:317–24.
Carrasco-Garrido P, Jiminez-Garcia R, Hernandez Barrera V, Gil de Miguel A.
Predictive factors of self-medicated drug use among the Spanish adult population. Pharmacoepidemiol Drug Saf 2008;17:193–9.
Elliott RA. Problems with medication use in the elderly: An Australian perspective. Journal of Pharmacy Practice and Research 2006;36:58–66.
Thompson S, Stewart K. Prescription medication use practices among noninstitutionalised older persons. International Journal of Pharmacy Practice
2001;9:141–52.
Sorensen L, Stokes JA, Purdie DM, Woodward M, Roberts MS. Medication
management at home: Medication-related risk factors associated with poor
health outcomes. Age Ageing 2005;34:626–32.
Neafsey PJ, Jarrin O, Luciano S, Coffman MJ. Self-medication practices of
Spanish-speaking older adults in Hartford, Connecticut. Hispanic Health Care
International 2007;5:169–79.
Linden K, Jormanainen V, Pietila K, Sahi T. Medicine use by Finnish female conscripts during voluntary military service. Mil Med 2006;171:710–6.
Hall AJ, Logan JE, Toblin RL, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA 2008;300:2613.
Berzanskyte A, Valinteliene R, Haaijer-Ruskamp FM, Gurevicius R, Grigoryan
L. Self-medication with antibiotics in Lithuania. Int J Occ Med Environ Health
2006;19:246–53.
GrigoryanL, Burgerhof JGM, Haaijer-Ruskamp FM, et al. Is self-medication
with antibiotics in Europe driven by prescribed use? J Antimicrob Chemother
2007;59:152–6.
Larson EL, Dilone J, Garcia M, Smolowitz J. Factors which influence Latino
community members to self-prescribe antibiotics. Nurs Res 2006;55:94–102.

correspondence afp@racgp.org.au

Reprinted from Australian Family Physician Vol. 38, No. 10, October 2009 819

